CTAS vs TRI vs CPRT
161 measures in 16 categories, one definition each, computed from filings and market data.
CTAS70.8
Cintas Corporation
Industrials · Specialty Business Services
$213.69 +0.30%$84.9B mkt cap
Score DNA
TRI69.2
Thomson Reuters Corporation
Industrials · Specialty Business Services
$109.01 +1.04%$47.2B mkt cap
Score DNA
CPRT66.2
Copart, Inc.
Industrials · Specialty Business Services
$27.87 +0.43%$25.8B mkt cap
Score DNA
Price, rebased to 100 three years ago
CTAS TRI CPRT · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 1 | 0 | 1 |
| Last Congress purchase | 2026-06-02 | — | 2026-09-25 |
| 13F net change in holders | −5 | +406 | −18 |
| ETFs adding shares, 30d | 1,283 | 64 | 1,011 |
| ETFs trimming, 30d | 1,027 | 31 | 949 |
| Net ETF funds, 30d | +256 | +33 | +62 |
Valuation
16 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| P/E (TTM) | 41.2x
80th
|
28.4x
52nd
|
17.4x
24th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 2.71
82nd
|
— | 2.58
64th
|
| Price / sales | 7.3x
97th
|
6.0x
93rd
|
5.5x
86th
|
| Price / book | 16.3x
100th
|
4.3x
81st
|
2.8x
58th
|
| Price / tangible book | 59.0x
91st
|
— | 3.3x
27th
|
| Price / free cash flow | 41.7x
92nd
|
21.3x
69th
|
20.4x
65th
|
| Price / operating cash flow | 34.9x
96th
|
16.5x
75th
|
16.1x
71st
|
| Enterprise value | $87.3B
100th
|
$49.8B
97th
|
$21.4B
93rd
|
| EV / sales | 7.6x
97th
|
6.4x
93rd
|
4.6x
86th
|
| EV / EBITDA | 27.1x
93rd
|
15.1x
71st
|
10.4x
36th
|
| EV / EBIT | 32.3x
85th
|
21.4x
58th
|
11.7x
27th
|
| EV / free cash flow | 42.9x
88th
|
22.5x
65th
|
16.9x
46th
|
| Earnings yield | 2.4%
31st
|
3.5%
55th
|
5.7%
79th
|
| FCF yield | 2.4%
17th
|
4.7%
38th
|
4.9%
41st
|
| Operating cash flow yield | 2.9%
7th
|
6.1%
28th
|
6.2%
31st
|
| Graham number (per share) | $38.42
73rd
|
$46.47
91st
|
$18.22
27th
|
Profitability (TTM)
12 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| Gross margin | 51.0%
72nd
|
66.5%
93rd
|
44.7%
62nd
|
| EBITDA margin | 27.8%
79th
|
42.2%
97th
|
44.3%
100th
|
| Operating margin | 23.4%
90th
|
27.6%
97th
|
35.4%
100th
|
| EBIT margin | 23.4%
86th
|
29.7%
97th
|
39.3%
100th
|
| Net margin | 17.8%
90th
|
21.2%
97th
|
31.8%
100th
|
| NOPAT margin | 18.5%
90th
|
21.6%
97th
|
28.6%
100th
|
| FCF margin | 17.6%
79th
|
28.3%
96th
|
27.2%
89th
|
| Operating cash flow margin | 21.1%
71st
|
36.6%
93rd
|
34.4%
89th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 27.4%
66th
|
26.9%
62nd
|
9.2%
21st
|
| Stock comp / revenue | 1.1%
55th
|
0.0%
0th
|
0.8%
45th
|
| Effective tax rate | 20.7%
21st
|
22.0%
45th
|
19.3%
7th
|
Returns on capital
11 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| ROE (on average equity) | 41.4%
100th
|
14.0%
54th
|
16.2%
77th
|
| ROA | 20.1%
97th
|
9.2%
79th
|
14.8%
86th
|
| ROIC | 27.9%
89th
|
12.3%
64th
|
28.4%
93rd
|
| ROCE | 34.0%
100th
|
17.1%
79th
|
19.7%
86th
|
| Return on tangible assets | 26.4%
100th
|
12.9%
76th
|
18.2%
90th
|
| Cash ROIC (OCF / invested capital) | 31.7%
82nd
|
20.9%
64th
|
34.2%
86th
|
| Gross profitability (GP / assets) | 55.3%
86th
|
28.8%
62nd
|
20.8%
52nd
|
| ROIC, 3-yr average | 22.7%
88th
|
11.2%
72nd
|
28.5%
92nd
|
| ROIC, 5-yr average | 24.3%
83rd
|
11.3%
71st
|
65.4%
100th
|
| ROE, 5-yr average | 38.4%
100th
|
14.1%
62nd
|
19.1%
79th
|
| Incremental ROIC | 138.8%
89th
|
-92.4%
11th
|
-76.9%
19th
|
Growth
17 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| Revenue growth (TTM YoY) | 9.5%
46th
|
7.0%
39th
|
0.4%
14th
|
| Revenue growth (QoQ) | 3.7%
50th
|
-6.4%
14th
|
-6.8%
11th
|
| Revenue CAGR, 3 yr | 8.7%
60th
|
5.2%
44th
|
6.4%
48th
|
| Revenue CAGR, 5 yr | 9.7%
52nd
|
4.9%
16th
|
11.6%
60th
|
| Gross profit CAGR, 3 yr | 11.2%
60th
|
-1.3%
28th
|
6.3%
40th
|
| Operating income CAGR, 3 yr | 13.2%
65th
|
-2.9%
20th
|
3.6%
35th
|
| Net income growth (TTM YoY) | 11.3%
40th
|
1.7%
30th
|
-4.4%
20th
|
| Net income CAGR, 3 yr | 14.3%
61st
|
-7.4%
22nd
|
6.2%
50th
|
| EPS growth (TTM YoY) | 12.7%
40th
|
4.6%
25th
|
-2.3%
20th
|
| EPS CAGR, 3 yr | 15.2%
61st
|
-5.3%
22nd
|
6.7%
50th
|
| EPS CAGR, 5 yr | 13.6%
82nd
|
-23.4%
0th
|
9.8%
71st
|
| FCF growth (TTM YoY) | 19.9%
50th
|
16.9%
41st
|
3.0%
32nd
|
| FCF CAGR, 3 yr | 17.0%
45th
|
10.8%
23rd
|
14.3%
41st
|
| Operating cash flow CAGR, 3 yr | 14.1%
52nd
|
9.6%
35th
|
5.6%
22nd
|
| Book value CAGR, 3 yr | 9.4%
67th
|
2.1%
29th
|
15.5%
83rd
|
| Dividend CAGR, 3 yr | 5.6%
80th
|
4.9%
73rd
|
— |
| Sustainable growth rate | 26.8%
91st
|
5.0%
41st
|
16.2%
82nd
|
Margin history & stability
7 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| Gross margin, 3-yr average | 49.8%
73rd
|
73.7%
100th
|
45.0%
62nd
|
| Operating margin, 3-yr average | 22.7%
88th
|
28.3%
92nd
|
36.3%
100th
|
| Net margin, 3-yr average | 17.4%
92nd
|
25.7%
96th
|
32.5%
100th
|
| FCF margin, 3-yr average | 17.4%
85th
|
27.3%
96th
|
25.4%
88th
|
| Revenue stability (0-1) | 1.00
100th
|
0.98
81st
|
0.94
58th
|
| Earnings stability (0-1) | 0.98
96th
|
0.29
42nd
|
0.93
88th
|
| Margin stability (0-1) | 0.96
81st
|
0.80
27th
|
0.95
73rd
|
Liquidity (latest quarter)
7 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| Cash & short-term investments | $243.6M
62nd
|
$576.3M
93rd
|
$4.5B
100th
|
| Net cash (− = net debt) | −$2.5B
10th
|
−$2.6B
7th
|
$4.4B
100th
|
| Working capital | $1.2B
97th
|
−$2.2B
0th
|
$4.9B
100th
|
| Current ratio | 1.45
56th
|
0.51
4th
|
7.91
100th
|
| Quick ratio | 1.29
48th
|
0.51
4th
|
7.84
100th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.09
22nd
|
0.13
37th
|
6.38
100th
|
| Defensive interval (days) | 209 days
21st
|
204 days
17th
|
4,485 days
100th
|
Leverage & solvency (latest quarter)
13 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| Total debt | $2.7B
86th
|
$3.2B
93rd
|
$88.4M
28th
|
| Debt / equity | 0.52
50th
|
0.29
31st
|
0.01
4th
|
| Net debt / equity | 0.47
50th
|
0.23
38th
|
−0.48
8th
|
| Debt / assets | 25.5%
45th
|
17.6%
34th
|
0.9%
7th
|
| Debt / capital | 34.3%
50th
|
22.2%
31st
|
1.0%
4th
|
| Debt / EBITDA | 0.84
29th
|
0.96
32nd
|
0.04
7th
|
| Net debt / EBITDA | 0.77
36th
|
0.79
39th
|
−2.13
11th
|
| Interest coverage (EBIT / interest) | 25.3x
100th
|
13.8x
83rd
|
— |
| Cash interest coverage | 22.8x
88th
|
16.9x
75th
|
— |
| Debt payback (years of OCF) | 1.1 yrs
32nd
|
1.1 yrs
29th
|
0.1 yrs
11th
|
| Liabilities / assets | 51.1%
45th
|
38.5%
24th
|
9.1%
3rd
|
| IS credit model rating | AAA | AA+ | AA+ |
| Implied credit spread (bps) | 50
0th
|
65
3rd
|
65
3rd
|
Efficiency
11 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| Asset turnover | 1.13
76th
|
0.43
21st
|
0.46
31st
|
| Fixed asset turnover | 5.66
31st
|
22.93
86th
|
1.22
7th
|
| Inventory turnover | 12.8
36th
|
— | 56.7
93rd
|
| Receivables turnover | 7.7
61st
|
7.1
54th
|
5.9
29th
|
| Days sales outstanding | 47 days
41st
|
52 days
48th
|
61 days
72nd
|
| Days inventory outstanding | 28 days
64th
|
— | 6 days
7th
|
| Days payables outstanding | 31 days
50th
|
74 days
93rd
|
60 days
86th
|
| Cash conversion cycle (days) | 45 days
75th
|
−22 days
14th
|
8 days
32nd
|
| Capex / revenue | 3.5%
50th
|
8.3%
86th
|
7.2%
79th
|
| Capex / depreciation | 0.78
59th
|
0.67
52nd
|
1.46
96th
|
| Operating expense ratio | 27.9%
52nd
|
9.5%
21st
|
9.8%
24th
|
Cash flow & earnings quality
7 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| Operating cash flow / net income | 1.18
8th
|
1.72
28th
|
1.08
4th
|
| FCF / net income | 0.99
20th
|
1.33
40th
|
0.85
12th
|
| FCF / operating cash flow | 83.5%
74th
|
77.3%
59th
|
79.0%
67th
|
| Capex / operating cash flow | 16.5%
26th
|
22.7%
41st
|
21.0%
33rd
|
| Accruals ratio | -3.6%
75th
|
-6.7%
29th
|
-1.2%
93rd
|
| Sloan accruals ratio | -11.3%
10th
|
-14.1%
7th
|
-3.2%
69th
|
| Earnings quality score (0-1) | 1.00
56th
|
0.75
4th
|
1.00
56th
|
Scores & forensic checks
15 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| IS score | 71
90th
|
69
86th
|
66
79th
|
| IS profitability | 84
100th
|
67
83rd
|
79
93rd
|
| IS growth | 58
57th
|
46
32nd
|
37
18th
|
| IS value | 33
21st
|
54
59th
|
56
66th
|
| IS momentum | 80
46th
|
75
36th
|
62
21st
|
| IS risk (safety) | 100
68th
|
100
68th
|
100
68th
|
| IS quality | 88
93rd
|
81
86th
|
84
90th
|
| IS balance sheet | 67
76th
|
62
69th
|
92
100th
|
| IS earnings quality | 77
79th
|
72
52nd
|
76
69th
|
| IS cash flow | 71
72nd
|
81
90th
|
77
76th
|
| Piotroski F-score (0-9) | 8
90th
|
6
28th
|
6
28th
|
| Altman Z-score | 12.8
96th
|
4.5
75th
|
21.1
100th
|
| Beneish M-score | −2.55
64th
|
−2.07
86th
|
−2.64
46th
|
| Ohlson O-score | −9.05
19th
|
−9.27
15th
|
−14.38
0th
|
| IS credit score | 96
100th
|
93
90th
|
91
83rd
|
Size (TTM)
8 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| Market cap | $84.9B
100th
|
$47.2B
97th
|
$25.8B
93rd
|
| Revenue | $11.6B
93rd
|
$7.8B
86th
|
$4.7B
76th
|
| EBITDA | $3.2B
97th
|
$3.3B
100th
|
$2.1B
90th
|
| Net income | $2.1B
100th
|
$1.7B
97th
|
$1.5B
93rd
|
| Free cash flow | $2.0B
93rd
|
$2.2B
97th
|
$1.3B
86th
|
| Total assets | $10.7B
86th
|
$18.1B
100th
|
$10.0B
83rd
|
| Shareholders' equity | $5.2B
86th
|
$11.1B
100th
|
$9.1B
97th
|
| Employees | 48,100
89th
|
27,100
79th
|
21,000
71st
|
Price performance
9 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| 1 day | +0.3% | +1.0% | +0.4% |
| 1 week | +5.6% | +5.6% | +2.0% |
| 1 month | +8.0% | +9.6% | −6.0% |
| 3 months | +6.2% | +14.2% | +1.4% |
| 6 months | +19.9% | +17.2% | −16.7% |
| Year to date | +16.5% | −13.1% | −26.2% |
| 1 year | +15.2% | −31.3% | −37.5% |
| 3 years, cumulative | +71.2% | −11.9% | −39.6% |
| 5 years, cumulative | +122.3% | +1.9% | −20.6% |
Technicals
4 measures| Measure | CTAS | TRI | CPRT |
|---|---|---|---|
| RSI 14 | 71.7 | 65.8 | 47.4 |
| From 52-week high | −2.2% | −33.4% | −39.3% |
| From 52-week low | +33.3% | +42.9% | +8.4% |
| Beta | 0.92 | 0.17 | 1.06 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17